CD4+CD25+Foxp3+ regulatory T cells depletion may attenuate the development of silica-induced lung fibrosis in mice

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Liu, Fangwei ^a   Liu, Jie ^a   Weng, Dong ^a   Chen, Ying ^a   Song, Laiyu ^a   He, Qincheng ^a   Chen, Jie ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYTOKINE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; SILICON DIOXIDE; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR ALPHA; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; LEUKOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; IMMUNOMODULATION; INFLAMMATION; LUNG FIBROSIS; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SILICOSIS; TH1 CELL; TH2 CELL; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; FIBROSIS; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; PATHOLOGY; PNEUMONIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; ANTIGENS, CD; DISEASE PROGRESSION; FEMALE; FIBROSIS; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-4; LUNG; MICE; MICE, INBRED C57BL; PNEUMONIA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SILICON DIOXIDE; SILICOSIS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 78149483354     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015404     Document Type: Article

References (39)

1. Brown JM, Swindle EJ, Kushnir-Sukhov NM, Holian A, Metcalfe DD (2007) Silica-directed mast cell activation is enhanced by scavenger receptors. Am J Respir Cell Mol Biol 36: 43-52.
2. Kuhlmann UC, Chwieralski CE, van den Brule S, Rocken C, Reinhold D, et al. (2009) Modulation of cytokine production and silica-induced lung fibrosis by inhibitors of aminopeptidase N and of dipeptidyl peptidase-IV-related proteases. Life Sci 84: 1-11.
3. Huaux F (2007) New developments in the understanding of immunology in silicosis. Curr Opin Allergy Clin Immunol 7: 168-173.
4. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, et al. (2008) Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320: 674-677.
5. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856.
6. Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, et al. (2008) The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci U S A 105: 9035-9040.
7. Rom WN, Travis WD (1992) Lymphocyte-macrophage alveolitis in nonsmoking individuals occupationally exposed to asbestos. Chest 101: 779-786.
8. Ueki A, Yamaguchi M, Ueki H, Watanabe Y, Ohsawa G, et al. (1994) Polyclonal human T-cell activation by silicate in vitro. Immunology 82: 332-335.
9. Suzuki N, Ohta K, Horiuchi T, Takizawa H, Ueda T, et al. (1996) T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice. Thorax 51: 1036-1042.
10. Brown JM, Pfau JC, Holian A (2004) Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhal Toxicol 16: 133-139.
11. Davis GS, Holmes CE, Pfeiffer LM, Hemenway DR (2001) Lymphocytes, lymphokines, and silicosis. J Environ Pathol Toxicol Oncol 20(Suppl 1): 53-65.
12. Chen Y, Chen J, Dong J, Liu W (2005) Antifibrotic effect of interferon gamma in silicosis model of rat. Toxicol Lett 155: 353-360.
13. Barbarin V, Xing Z, Delos M, Lison D, Huaux F (2005) Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. Am J Physiol Lung Cell Mol Physiol 288: L841-848.
14. Arras M, Huaux F, Vink A, Delos M, Coutelier JP, et al. (2001) Interleukin-9 reduces lung fibrosis and type 2 immune polarization induced by silica particles in a murine model. Am J Respir Cell Mol Biol 24: 368-375.
15. Misson P, Brombacher F, Delos M, Lison D, Huaux F (2007) Type 2 immune response associated with silicosis is not instrumental in the development of the disease. Am J Physiol Lung Cell Mol Physiol 292: L107-113.
16. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL (2002) CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507.
17. Suvas S, Kumaraguru U, Pack CD, Lee S, Rouse BT (2003) CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 198: 889-901.
18. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, et al. (2003) CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 9: 1144-1150.
19. Dai Z, Li Q, Wang Y, Gao G, Diggs LS, et al. (2004) CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30- dependent mechanism. J Clin Invest 113: 310-317.
20. Hawrylowicz CM, O'Garra A (2005) Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma. Nat Rev Immunol 5: 271-283.
21. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, et al. (2006) Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212: 28-50.
22. Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8: 523-532.
23. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24: 99-146.
24. O'Garra A, Barrat FJ, Castro AG, Vicari A, Hawrylowicz C (2008) Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev 223: 114-131.
25. Gutcher I, Becher B (2007) APC-derived cytokines and T cell polarization in autoimmune inflammation. J Clin Invest 117: 1119-1127.
26. Knutson KL, Disis ML (2005) Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother 54: 721-728.
27. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, et al. (2004) Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 363: 608-615.
28. Grindebacke H, Wing K, Andersson AC, Suri-Payer E, Rak S, et al. (2004) Defective suppression of Th2 cytokines by CD4CD25 regulatory T cells in birch allergics during birch pollen season. Clin Exp Allergy 34: 1364-1372.
29. Bellinghausen I, Klostermann B, Knop J, Saloga J (2003) Human CD4+CD25+ T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol 111: 862-868.
30. Suto A, Nakajima H, Kagami SI, Suzuki K, Saito Y, et al. (2001) Role of CD4(+) CD25(+) regulatory T cells in T helper 2 cell-mediated allergic inflammation in the airways. Am J Respir Crit Care Med 164: 680-687.
31. Jaffar Z, Sivakuru T, Roberts K (2004) CD4+CD25+ T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J Immunol 172: 3842-3849.
32. Kearley J, Barker JE, Robinson DS, Lloyd CM (2005) Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 202: 1539-1547.
33. Doganci A, Eigenbrod T, Krug N, De Sanctis GT, Hausding M, et al. (2005) The IL-6R alpha chain controls lung CD4+CD25+ Treg development and function during allergic airway inflammation in vivo. J Clin Invest 115: 313-325.
34. Saito K, Torii M, Ma N, Tsuchiya T, Wang L, et al. (2008) Differential regulatory function of resting and preactivated allergen-specific CD4+ CD25+ regulatory T cells in Th2-type airway inflammation. J Immunol 181: 6889-6897.
35. Wu P, Miura Y, Hyodoh F, Nishimura Y, Hatayama T, et al. (2006) Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients. Int J Immunopathol Pharmacol 19: 357-368.
36. Haeryfar SM, DiPaolo RJ, Tscharke DC, Bennink JR, Yewdell JW (2005) Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities. J Immunol 174: 3344-3351.
37. Lewkowich IP, Herman NS, Schleifer KW, Dance MP, Chen BL, et al. (2005) CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med 202: 1549-1561.
38. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, et al. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
39. Wan YY, Flavell RA (2005) Identifying Foxp3-expressing suppressor T cells with a bicistronic reporter. Proc Natl Acad Sci U S A 102: 5126-5131.